CORE TECHNOLOGY
With the rapid improvement of pharmaceutical technology and the approaching of aging society, we focus on the development of innovative healthcare technology of Acute and Critical Care and Anti-aging and Preventive Medicine.
Quality Assurance
01
南光製藥藉由全面品質管理的具體作法，已通過國內衛生署PIC/S GMP及日本PMDA查核，將持續以符合FDA cGMP和歐盟PIC/S GMP並成為全方位國際化藥廠為目標。
Social Responsibility
02
南光化學製藥公司在追求企業成長與產能提升的同時，能不忘對環境保護的責任與義務，遵循著「減廢減費、珍惜資源，綠色產品、關懷環境」的環境政策。
THE NEWS
-
Hot News
-
Media Report
Congratulation to Nang Kuang for Deloitte Private BMC Award.MORE292021 MarNangKuang’sManagementPerformanceWellRecognizedafterEndeavoringinPharmaceuticalIndustryfor60YearsCongratulationtoNangKuangforbeingawardedthefirstDeloittePrivateManagementExcellenceAward！OurNewsletterDeloittePrivate,theworld'slargestaccountingfirm,selectedthe"BestManagedCompanies,BMC"forthefirsttimeinTaiwanthisyear.Afterstrictassessmentandfiercecompetition,NangKuangPharmaceuticalCo.,LtdstoodoutfromlotsofcompetitorsandbecamethefirstbiopharmaceuticalcompanyinTaiwantowinthisaward.Afewdaysago,thesponsor,DeloittePrivate,hadannouncedthatfourenterprises,including,CosmosD&MCo.,Ltd.,I-JangCo.,Ltd.,NangKuangPharmaceuticalCo.,Ltd.,andSunjuiceHoldingsCo.,Ltd.,wereselectedaswinnersofthefirst"BestManagedCompaniesProgram".ThesponsorexpressedthatDeloittePrivateBestManagedCompaniesProgramhasbeenheldfor27yearsinmorethan20countries/areasglobally.Thepurposeoftheprogramistoidentifyandrecognizecompanieswithexcellentmanagementideasandpracticesbasedonthefourpillarsofcorporatestrategy,competenceandinnovation,corporatecultureandcommitment,andcorporatemanagementandfinance.NangKuangPharmaceuticalCo.,Ltd.hasbeenendeavoringintheindustryfor58yearsinTaiwanandhasinvestedalotofresourcesinbothbusinessmodelandhumanresourcedevelopment.Theabilitytostrengthensustainableoperationsthroughforward-lookingstrategicdevelopmentisthekeyforNangKuangtowintheaward.NangKuangPharmaceuticalCo.,Ltd.wasestablishedin1963.Startingasaprofessionalmanufacturerofsterileinjectionproducts,NangKuangmeetstheindustrialdevelopingtrendofenvironmentalprotectionandmedicationsafetywithitsinnovativepharmaceuticaltechnology.IthasestablishedgoodfoundationinTaiwanandenteredinternationalmarket.It’salsothefirstdomesticpharmaceuticalcompanyinTaiwantoexportexcellentproductstoJapanandtheUnitedStates.Inaddition,NangKuangadjustsitsoperatingstrategyinatimelymannerinresponsetochangesintheinternalandexternalenvironmentsoftheindustry,andcultivatesbusinessleadersandsuccessorswithabroadvisiontosuccessfullyrespondtotherapidchangesinthemarkets.Therefore,NangKuangistrulyworthyoftheawardofthefirstDeloittePrivateBMCprograminTaiwan.ThewinnerofthefirstDeloittePrivateBestManagedCompaniesProgram–NangKuangPharmaceuticalCo.,Ltd.
/ Messages from the chairman and the general manager /
南光化學製藥
南光化學製藥
To Secure Health, We Always Stand at the Forefront
Nangkuang plotted out the whole new business structure with prospective vision and innovative values. With the expectation of sustainable operation and attaining the summit of business, Nangkuang has deeply devoted itself to the development of acute and critical care medicines and preventive medicines, and aimed to become a leading brand of public healthcare.
READ MORE南光化學製藥
董事長
南光化學製藥
總經理
Providing excellent pharmaceuticals to safeguard public health
Nangkuang deployed its overseas business with international marketing strategy. In addition to the success of entering into Japanese market, its business in Asia-pacific market also covers China and south-east Asia. Nangkuang also actively forms technical and marketing strategic alliances with European and American pharmaceutical companies.
